Catalent

CTLT NYSE
53.16
+0.46
+0.87%
After Hours: 53.16 0 0.00% 16:39 06/25 EDT
Open
52.92
Prev Close
52.70
High
53.28
Low
52.12
Volume
731.76K
Avg Vol (3M)
823.56K
52 Week High
54.10
52 Week Low
29.23
% Turnover
0.50%
Market Cap
7.75B
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Catalent CTLT stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels. The Drug Delivery Solutions segment is engaged in the formulation, development and manufacturing of prescription and consumer and animal health products; blow-fill seal unit dose manufacturing; biologic cell line development; analytical and bioanalytical development, and testing services. The Clinical Supply Services segment is engaged in manufacturing, packaging, labeling, storage, distribution and inventory management for clinical trials of drugs and biologics for patient kits; FastChain clinical supply service; clinical e-solutions and informatics, and global comparator sourcing services.
MORE >

Recently

Name
Price
%Change